Aardvark Therapeutics AARD
NASDAQ AARD
$5.35 +0.08 (+1.52%)
At close: Sep 29, 2026 · 4:00 PM EDT

Aardvark Therapeutics (AARD) Payables (2024 - 2026)

Updated

Aardvark Therapeutics (AARD) reported Payables of $2.09 million for Q2 2026, down 58.7% from $5.06 million a year earlier and down 53.6% from the prior quarter.

Analysis

Aardvark Therapeutics (AARD) Payables (2024 - 2026) Analysis & Trends

At the end of FY2025, Aardvark Therapeutics posted Payables of $2.07 million, down 9.8% from FY2024.

  • By year, Payables came in at $2.3 million in FY2024.
  • Five-year quarterly Payables spans a low of $2.07 million in Q4 2025 and a high of $5.06 million in Q2 2025.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $4.49 million (Q1 2026), $2.07 million (Q4 2025) and $4.44 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 20.92 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.30 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 5.96 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -22.89 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 674.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 7.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 429.50 Mn
10 Aardvark Therapeutics 115.33 Mn 41.43 Mn - 2.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.09 Mn
Mar 31, 2026 4.49 Mn
Dec 31, 2025 2.07 Mn
Sep 30, 2025 4.44 Mn
Jun 30, 2025 5.06 Mn
Mar 31, 2025 2.56 Mn
Dec 31, 2024 2.30 Mn
API Access

Aardvark Therapeutics Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=AARD&period=max&api_key=YOUR_API_KEY